Scanty AFB smears: what's in a name?
a. van deun;a. hamid salim;e. cooreman;p.daru;a. p. k. das;k. j. m. aung;h. l. rieder; zhang zong de

..............page:121-126

Patterns of tuberculosis risk over time among recent immigrants to Ontario, Canada
m. i. creatore;m. lam;w. l. wobeser; xu min

..............page:114-120

Management of multidrug-resistant tuberculosis in Italy
g. ferrara;l. richeldi;m. bugiani;d. cirillo;g. besozzi;s. nutini;l. casali;f. fiorentini;l. r. codecasa;g. b. migliori; xu min

..............page:107-113

Deteriorated tuberculosis drugs and management system problems in lower southern Thailand
k. rookkapan;v. chongsuvivatwong;s. kasiwong;s. pariyawatee;y. kasetcharoen;p. pungrassami; ma

..............page:101-106

Is the combination of pyrazinamide plus rifampicin safe for treating latent tuberculosis infection in persons not infected by the human immunodeficiency virus?
c. tortajada;j. mart nez-lacasa;f. s nchez;a. jim nez-fuentes;m. l. de souza;j. f. garc a;j. a. mart nez;j. a. cayl ; ma

..............page:96-100

Severe hepatotoxicity due to anti-tuberculosis drugs in Spain
j. r. tost;r. vidal;j. cayl ;d. d az-cabanela;a. jim nez;j. m. broquetas;the study group for severe hepatotoxicity due to anti-tuberculosis drugs in spain; ma

..............page:90-95

Persistence of a strain of Mycobacterium tuberculosis in a prison system
k.ljaz;z.yang;g. templeton;w. w. stead;j. h. bates;m. d. cave; zhang zong de

..............page:85-89

Choosing a research study design and selecting a population to study
d. a. enarson;s. m. kennedy;d. l. miller; zhang zong de

..............page:81-84